Konu "Durability of Antitumor Activity and Safety" için Tıp Fakültesi listeleme
Toplam kayıt 1, listelenen: 1-1
-
Five-year outcome and safety in patients treated with immune checkpoint blockade therapies for urothelial carcinoma: Experience from real-world clinical practice
(CIG Media Group, 2023)This 5-year analysis of real-world data confirms the durable response and long-term survival with ICTs in a broader range of patients with metastatic urothelial carcinoma. After 24 months, PFS and OS curves remained nearly ...